Attachments
Note: Not all attachments are visible to the general public. Research URLs will go live after the embargo ends.
Research
American College of Cardiology, Web page
Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Editorial / Opinion
American College of Cardiology, Web page
Please link to the article in online versions of your report (the URL will go live after the embargo ends).
Journal/
conference: Journal of the American College of Cardiology
conference: Journal of the American College of Cardiology
Research:Paper
Organisation/s:
Monash University, Baker Heart and Diabetes Institute, The Alfred Hospital
Funder:
The study was supported by Ambulance Victoria and the Department
of Cardiology, Alfred Health. Drs Dawson and Bloom are supported by
National Health and Medical Research Council of Australia (NHMRC)
and National Heart Foundation (NHF) postgraduate scholarships. Dr
E. Nehme is supported by an NHMRC postgraduate scholarship. Dr Z.
Nehme is supported by an NHF fellowship. Drs Taylor, Kaye, and
Smith are supported by NHMRC grants. Dr Stub is supported by NHF
grants. Dr Nicholls has received research support from AstraZeneca,
New Amsterdam Pharma, Amgen, Anthera, Eli Lilly, Esperion,
Novartis, Cerenis, The Medicines Company, Resverlogix, InfrareDx,
Roche, Sanofi-Regeneron, and LipoScience; and has been a consultant
for AstraZeneca, Amarin, Akcea, Eli Lilly, Anthera, Omthera, Merck,
Takeda, Resverlogix, Sanofi-Regeneron, CSL Behring, Esperion,
Boehringer Ingelheim, Vaxxinity, and Sequiris